Last reviewed · How we verify

NCT03513107

Osteoporosis Screening Tools' Re-validation in Egypt Guide for the Management of the Condition in Males

Completed Last updated 6 February 2024
What this trial tests

trial testing ospeoporosis score in Osteoporosis in 103 participants. Completed in 30 September 2018.

Timeline
15 January 2018
Primary endpoint
30 September 2018
30 September 2018

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment103
Start date15 January 2018
Primary completion30 September 2018
Estimated completion30 September 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

18 and older, any sex, with Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To demonstrate the predictive ability of the different screening scores (i.e. OST, ORAI, ABONE, body weight criterion, age alone or others) and their potential use in the primary care setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoporosis

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03513107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing